Kuwano A, Miyazaki M, Yada M, Tanaka K, Koga Y, Masumoto A
    
    
    Exp Ther Med. 2023; 26(3):441.
  
  
    PMID: 37614433
    
          PMC: 10443030.
    
          DOI: 10.3892/etm.2023.12140.
      
 
                                  
  
    Zhan X, Gao Y, Xu J, Wu D, Wang P, Zhou H
    
    
    Int J Immunopathol Pharmacol. 2023; 37:3946320231190898.
  
  
    PMID: 37614092
    
          PMC: 10467195.
    
          DOI: 10.1177/03946320231190898.
      
 
                                  
  
    Huang P, Hu Y, Liu Y, Li J, Zhang Y
    
    
    J Hepatocell Carcinoma. 2023; 10:959-978.
  
  
    PMID: 37377841
    
          PMC: 10292625.
    
          DOI: 10.2147/JHC.S417501.
      
 
                                  
  
    Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q
    
    
    Signal Transduct Target Ther. 2023; 8(1):204.
  
  
    PMID: 37208335
    
          PMC: 10196327.
    
          DOI: 10.1038/s41392-023-01468-7.
      
 
                                  
  
    Boycott C, Beetch M, Yang T, Lubecka K, Ma Y, Zhang J
    
    
    Epigenetics. 2022; 17(11):1513-1534.
  
  
    PMID: 35502615
    
          PMC: 9586690.
    
          DOI: 10.1080/15592294.2022.2069386.
      
 
                              
              
                              
                                      
  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
  
    Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P
    
    
    Eur J Nucl Med Mol Imaging. 2022; 49(5):1682-1699.
  
  
    PMID: 35146577
    
          PMC: 8940802.
    
          DOI: 10.1007/s00259-021-05600-z.
      
 
                                          
                                                          
  Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.
  
    Zhang K, Liu H, Yu M, Zhao H, Yang N, Bi X
    
    
    Front Oncol. 2021; 11:650173.
  
  
    PMID: 34458133
    
          PMC: 8397520.
    
          DOI: 10.3389/fonc.2021.650173.
      
 
                                          
                                                          
  A prognostic risk model based on immune-related genes predicts overall survival of patients with hepatocellular carcinoma.
  
    Pan B, Liu L, Li W
    
    
    Health Sci Rep. 2020; 3(4):e202.
  
  
    PMID: 33204848
    
          PMC: 7654629.
    
          DOI: 10.1002/hsr2.202.
      
 
                                          
                                                          
  A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
  
    Zhang B, Tang B, Gao J, Li J, Kong L, Qin L
    
    
    J Transl Med. 2020; 18(1):342.
  
  
    PMID: 32887635
    
          PMC: 7487492.
    
          DOI: 10.1186/s12967-020-02492-9.
      
 
                                          
                                                          
  Glutamic-Pyruvic Transaminase 1 Facilitates Alternative Fuels for Hepatocellular Carcinoma Growth-A Small Molecule Inhibitor, Berberine.
  
    Guo W, Tan H, Li S, Wang N, Feng Y
    
    
    Cancers (Basel). 2020; 12(7).
  
  
    PMID: 32660149
    
          PMC: 7408817.
    
          DOI: 10.3390/cancers12071854.
      
 
                                          
                                                          
  Radioembolization for the Treatment of Primary and Metastatic Liver Cancers.
  
    Lee E, Chung H, Jo J, So Y
    
    
    Nucl Med Mol Imaging. 2019; 53(6):367-373.
  
  
    PMID: 31867071
    
          PMC: 6898706.
    
          DOI: 10.1007/s13139-019-00615-9.
      
 
                                          
                                                          
  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.
  
    Liu X, Baecker A, Wu M, Zhou J, Yang J, Han R
    
    
    Liver Int. 2019; 39(8):1490-1503.
  
  
    PMID: 31228882
    
          PMC: 6705127.
    
          DOI: 10.1111/liv.14182.
      
 
                                          
                                                          
  INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma.
  
    Tang W, Yang L, Yang T, Liu M, Zhou Y, Lin J
    
    
    Onco Targets Ther. 2019; 12:3491-3507.
  
  
    PMID: 31123408
    
          PMC: 6511246.
    
          DOI: 10.2147/OTT.S196832.
      
 
                                          
                                                          
  Comparison of gene expression in liver regeneration and hepatocellular carcinoma formation.
  
    Yin L, Wang Y, Guo X, Xu C, Yu G
    
    
    Cancer Manag Res. 2018; 10:5691-5708.
  
  
    PMID: 30532592
    
          PMC: 6245377.
    
          DOI: 10.2147/CMAR.S172945.
      
 
                                          
                                                          
  Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
  
    Lien H, Jeng Y, Jhuang Y, Yuan R
    
    
    PLoS One. 2018; 13(10):e0206261.
  
  
    PMID: 30356299
    
          PMC: 6200274.
    
          DOI: 10.1371/journal.pone.0206261.
      
 
                                          
                                                          
  Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.
  
    Shi B, Zhang X, Chao L, Zheng Y, Tan Y, Wang L
    
    
    FEBS Open Bio. 2018; 8(9):1424-1436.
  
  
    PMID: 30186744
    
          PMC: 6120244.
    
          DOI: 10.1002/2211-5463.12483.
      
 
                                          
                                                          
  LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?.
  
    Kim S, Hwang J, Shin H, Choi S, Kang T, Jou S
    
    
    Eur Radiol. 2018; 29(1):186-194.
  
  
    PMID: 30073499
    
    
          DOI: 10.1007/s00330-018-5657-y.
      
 
                                          
                                                          
  Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?.
  
    Husing-Kabar A, Meister T, Kohler M, Domschke W, Kabar I, Wilms C
    
    
    United European Gastroenterol J. 2018; 6(3):413-421.
  
  
    PMID: 29774155
    
          PMC: 5949971.
    
          DOI: 10.1177/2050640617732886.
      
 
                                          
                                                          
  Clinical Characteristics of 130 Patients With Hepatocellular Carcinoma Followed at a Tertiary Hospital From Brazil.
  
    Teixeira A, Mente E, Cantao C, Sankarankutty A, Souza F, Motta T
    
    
    World J Oncol. 2017; 3(4):165-172.
  
  
    PMID: 29147300
    
          PMC: 5649839.
    
          DOI: 10.4021/wjon549w.
      
 
                                          
                                                          
  Association of polymorphisms in the heparanase gene (HPSE) with hepatocellular carcinoma in Chinese populations.
  
    Yu L, Zhang X, Zhai Y, Zhang H, Yue W, Zhang X
    
    
    Genet Mol Biol. 2017; 40(4):743-750.
  
  
    PMID: 28981558
    
          PMC: 5738625.
    
          DOI: 10.1590/1678-4685-GMB-2014-0338.